Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib
Trial Number
NCT03737643Contact Person
Status
Follow Up
Disease Site
Ovarian
Lead Cooperative Group
Participating Groups
AGO-AUST
BGOG
GEICO
GINECO
GOG-F
JGOG
KGOG
MaNGO
MITO
NSGO-CTU
PMHC